New postdoc fellow joins KI group to identify small molecules targeting p75NTR

Qiang Zhang obtained his  PhD at the Karolinska Institute in 2018, under the direction of Prof. Klas Wiman. His PhD thesis was entitled “Understanding p53 structure and targeting mutant p53 for improved cancer therapy”. Qiang joins our KI team to work on the identification of small molecules capable of modulating the activities of the p75 neurotrophic receptor p75NTR, based on the platform described in our recent article in Cell Chemical Biology.